Related content
Activities
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Activity: Talk or presentation types › Oral presentation
In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions
Activity: Talk or presentation types › Oral presentation
Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL
Activity: Talk or presentation types › Oral presentation
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Activity: Talk or presentation types › Oral presentation
Risk of cardiovascular events associated with BCR-ABL TKI in leukemic population: a systematic review and meta-analysis
Activity: Talk or presentation types › Oral presentation
Risk of vascular occlusive events with BCR-ABL TKIs in CML
Activity: Talk or presentation types › Oral presentation
The Namur Thrombosis and Hemostasis Center A gathering of experts from laboratory, clinical and regulatory field
Activity: Talk or presentation types › Invited talk
Research Output
In Vitro Effects of BCR-ABL Tyrosine Kinase Inhibitors on Endothelial Cells Survival and Functions
Research output: Contribution in Book/Catalog/Report/Conference proceeding › Conference contribution
In Vitro Effects of BCR-ABL Tyrosine Kinase Inhibitors on Endothelial Cells Survival and Functions
Research output: Contribution in Book/Catalog/Report/Conference proceeding › Conference contribution
BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival
Research output: Contribution to conference › Poster
Cardiovascular effect of BCR-ABL TKIs: a meta-analysis and systematic review of arterial and venous occlusive events
Research output: Contribution in Book/Catalog/Report/Conference proceeding › Conference contribution
In vitro investigations of the effect of BCR-ABL Tyrosine Kinase Inhibitors on endothelial cell viability
Research output: Contribution to conference › Poster
Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis
Research output: Contribution to journal › Article
In Vitro Effects of BCR-ABL Tyrosine Kinase Inhibitors on Endothelial Cells Survival and Functions
Research output: Contribution to conference › Poster
Impact of BCR-ABL Tyrosine Kinase Inhibitors on Atherosclerosis Plaque Rupture
Research output: Contribution to conference › Poster
Multiple causes of cardiotoxic effects in patients with chronic myeloid leukemia - Reply
Research output: Contribution to journal › Letter
Risk of cardiovascular events associated with BCR-ABL TKIs: a systematic review and meta-analysis
Research output: Contribution in Book/Catalog/Report/Conference proceeding › Conference contribution
An updated meta-analysis of the risks of arterial and venous occlusive events with new generation BCR-ABL TKIs in patients with chronic myeloid leukemia
Research output: Contribution to conference › Poster
Vascular safety profile of new generation BCR-ABL tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia
Research output: Contribution to journal › Article
BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?
Research output: Contribution to journal › Review article
Cardiovascular effect of BCR-ABL TKIs: a meta-analysis and systematic review of arterial and venous occlusive events
Research output: Contribution to conference › Poster
Meta-analysis of the risks of arterial and venous occlusive events with new generation BCR-ABL TKIs in patients with chronic myeloid leukaemia
Research output: Contribution to conference › Poster
Impact of BCR-ABL Tyrosine Kinase Inhibitors on Atherosclerosis Plaque Rupture
Research output: Contribution in Book/Catalog/Report/Conference proceeding › Conference contribution
Meta-analysis of the risks of arterial and venous occlusive events with new generation BCR-ABL TKIs in patients with chronic myeloid leukaemia
Research output: Contribution to journal › Article
In Vitro Effects of BCR-ABL Tyrosine Kinase Inhibitors on Endothelial Cells Survival and Functions
Research output: Contribution to conference › Poster
BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival
Research output: Contribution in Book/Catalog/Report/Conference proceeding › Conference contribution
Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival: A Systematic Review and Meta-analysis
Research output: Contribution to journal › Article
Press / Media
New-generation TKIs tied to increased risk of vascular occlusive events
Press/Media: Expert Comment
BCR-ABL Tyrosine Kinase Inhibitors May Increase Cardiovascular Events in Chronic Myeloid Leukemia
Press/Media: Expert Comment
Vascular Occlusion Risk Reviewed For CML New-Generation TKIs
Press/Media: Expert Comment
TKIs in CML Linked With Vascular Events
Press/Media: Expert Comment
BCR-ABL TKIs May Increase Cardiovascular Risk
Press/Media: Expert Comment
Prizes
Prix Léo Pharma Cancer & Thrombosis
Prize: Prize (including medals and awards)